Hemapheresis in pregnancy.
Plasma exchange in pregnancy has benefited those diseases that occur and are treated in the nonpregnant patient. In addition, special emphasis was given to diseases unique to pregnancy, such as hemolytic disease of the newborn, which is significantly modified by plasma exchange therapy. Fluid volumes, replacement solution, and techniques were discussed.
Dawson
R B
RB
University of Maryland School of Medicine, Baltimore.
D001781:Blood Component Removal; D001810:Blood Volume; D004899:Erythroblastosis, Fetal / Q000628:therapy; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D010953:Plasma Volume; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000628:therapy